Report adverse event
Log In/Register
Schizophrenia
Log in required
Local regulations restrict this content to healthcare professionals
Login
What is Schizophrenia?
Neurochemical basis of schizophrenia
Negative Symptoms
The Challenge of Negative Symptoms in Schizophrenia
Diagnosis
The Challenge of Diagnosing Negative Symptoms
Treatment
Treating Negative Symptoms of Schizophrenia
Log in required
Local regulations restrict this content to healthcare professionals
Login
Burden
Our Product
Log in required
Local regulations restrict this content to healthcare professionals
Login
Log in required
Local regulations restrict this content to healthcare professionals
Login
Mode of Action
The Mechanism of Action of Our Product
Log in required
Local regulations restrict this content to healthcare professionals
Login
Clinical Data
Efficacy
Our Product in patients with acute exacerbation of schizophrenia
Cariprazine in the Long-Term Treatment of Schizophrenia
Cariprazine Controls Negative Symptoms in Schizophrenia
Controlling Everyday Functioning with Cariprazine
Cariprazine's Effects on Primary and Secondary Negative Symptoms: The Pseudospecificity Problem
Safety
The Safety and Tolerability Profile of Our Product
The Management of Akathisia
Cariprazine and Weight Gain
Prescribing Our Product
Log in required
Local regulations restrict this content to healthcare professionals
Login
Log in required
Local regulations restrict this content to healthcare professionals
Login
Initiating
Log in required
Local regulations restrict this content to healthcare professionals
Login
Switching
Log in required
Local regulations restrict this content to healthcare professionals
Login
Dosing
Log in required
Local regulations restrict this content to healthcare professionals
Login
Drug-drug Interactions
Education & Resources
Log in required
Local regulations restrict this content to healthcare professionals
Login
Log in required
Local regulations restrict this content to healthcare professionals
Login
Diagnostic Tools
Diagnostic Tools
Literature Review
Clinical guide for treating negative symptoms in schizophrenia
Understanding the pathophysiology of the negative symptom dimensions of schizophrenia
Validation of the PANSS in two-factor negative symptom distinction
Benefits of Antipsychotic Polypharmacy in Schizophrenia Maintenance Therapy
Schizophrenia: Is It All Down To Your Genes?
Causal Relationship Between Cognitive Deficit and Risk of Schizophrenia
Connection Between Inflammation and Schizophrenia?
Potential benefits of using eHealth in the management of schizophrenia
Markers of Inflammation and Infection in Schizophrenia
The Role of Cannabis in Treatment-Resistant Schizophrenia
Childhood Behaviour to Predict Psychosis-Spectrum Diagnoses in Adulthood
Suicide Prevention
Investigating the Stigma Around Mental Health and When People Seek Professional Advice to Control Early Psychiatric Symptoms
Reversal of Schizophrenia Memory Deficits
Switching Antipsychotic Medications in Schizophrenia: Why, When and How?
Can Substance Abuse Cause Psychosis?
The Epstein–Barr Virus and Schizophrenia
News
COVID-19 and mental health
COVID-19 and the risk of developing mental health problems
COVID-19 and schizophrenia
COVID-19 and suicidality
Events
Log in required
Local regulations restrict this content to healthcare professionals
Login
ECNP 2020 Highlights
Symposium report: our product in schizophrenia
Can eating better improve people’s mental health?
Smartphone apps promise to support psychiatric practice
Exploring synaptic dysfunction in schizophrenia
Improving detection of young people at risk of psychoses
Exploring the druggable genome across psychiatric disorders
Managing psychosis in pregnancy still challenging
Early neurodevelopmental trauma induces adult psychosis
EPA 2020 Highlights
Antipsychotic monotherapy or polypharmacy: what’s the evidence?
Best of 2019 article overview of research in schizophrenia
Integrated treatment for people with schizophrenia
Metacognition key to improving functioning in schizophrenia?
Visit this section
Schizophrenia
What is Schizophrenia?
Neurochemical basis of schizophrenia
Negative Symptoms
The Challenge of Negative Symptoms in Schizophrenia
Diagnosis
The Challenge of Diagnosing Negative Symptoms
Treatment
Treating Negative Symptoms of Schizophrenia
Burden
Our Product
Mode of Action
The Mechanism of Action of Our Product
Clinical Data
Efficacy
Our Product in patients with acute exacerbation of schizophrenia
Cariprazine in the Long-Term Treatment of Schizophrenia
Cariprazine Controls Negative Symptoms in Schizophrenia
Controlling Everyday Functioning with Cariprazine
Cariprazine's Effects on Primary and Secondary Negative Symptoms: The Pseudospecificity Problem
Safety
The Safety and Tolerability Profile of Our Product
The Management of Akathisia
Cariprazine and Weight Gain
Prescribing Our Product
Initiating
Switching
Dosing
Drug-drug Interactions
Education & Resources
Diagnostic Tools
Diagnostic Tools
Literature Review
Clinical guide for treating negative symptoms in schizophrenia
Understanding the pathophysiology of the negative symptom dimensions of schizophrenia
Validation of the PANSS in two-factor negative symptom distinction
Benefits of Antipsychotic Polypharmacy in Schizophrenia Maintenance Therapy
Schizophrenia: Is It All Down To Your Genes?
Causal Relationship Between Cognitive Deficit and Risk of Schizophrenia
Connection Between Inflammation and Schizophrenia?
Potential benefits of using eHealth in the management of schizophrenia
Markers of Inflammation and Infection in Schizophrenia
The Role of Cannabis in Treatment-Resistant Schizophrenia
Childhood Behaviour to Predict Psychosis-Spectrum Diagnoses in Adulthood
Suicide Prevention
Investigating the Stigma Around Mental Health and When People Seek Professional Advice to Control Early Psychiatric Symptoms
Reversal of Schizophrenia Memory Deficits
Switching Antipsychotic Medications in Schizophrenia: Why, When and How?
Can Substance Abuse Cause Psychosis?
The Epstein–Barr Virus and Schizophrenia
News
COVID-19 and mental health
COVID-19 and the risk of developing mental health problems
COVID-19 and schizophrenia
COVID-19 and suicidality
Events
ECNP 2020 Highlights
Symposium report: our product in schizophrenia
Can eating better improve people’s mental health?
Smartphone apps promise to support psychiatric practice
Exploring synaptic dysfunction in schizophrenia
Improving detection of young people at risk of psychoses
Exploring the druggable genome across psychiatric disorders
Managing psychosis in pregnancy still challenging
Early neurodevelopmental trauma induces adult psychosis
EPA 2020 Highlights
Antipsychotic monotherapy or polypharmacy: what’s the evidence?
Best of 2019 article overview of research in schizophrenia
Integrated treatment for people with schizophrenia
Metacognition key to improving functioning in schizophrenia?
Report adverse event
website for members of the public
Log In | Register
Healthcare professionals
Public
DocCheck Login
Let us know you agree to cookies
Yes, I agree
No, Take me to settings
You are now leaving the site and will be re-directed to an external website.
Accept
Cancel
Showing
0
result(s).
Please log in to see
0
more result(s).